Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Crosses Below 200-Day Moving Average – Time to Sell?

Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $11.83 and traded as low as $11.20. Ono Pharmaceutical shares last traded at $11.20, with a volume of 7,370 shares.

Ono Pharmaceutical Stock Performance

The firm has a market cap of $5.26 billion, a PE ratio of 10.76 and a beta of 0.59. The stock has a 50-day moving average price of $10.06 and a 200 day moving average price of $11.81. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80.

Ono Pharmaceutical (OTCMKTS:OPHLF) last posted its quarterly earnings data on Monday, February 3rd. The company reported $0.21 EPS for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.10%.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.